Molecular Biomarkers of Disease for Diagnosis and Drug Development (223 views visite)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2019; 26(11): 1922-1923.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Editorial, Introductory Journal Article
Impact factor: 3.9, 5-year impact factor Impact factor a 5 anni: 3.7
Url: Not available. Non disponibile.
Keywords Parole chiave: Bacteria Chemistry, Bacterial Infections Diagnosis Physiopathology, Biomarkers Analysis, Tumor Analysis Physiology, Drug Development, Humans, Neoplasms Diagnosis Physiopathology
Affiliations Affiliazioni:
*** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples, Italy.,
References Riferimenti:
Not available. Non disponibili.
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2019; 26(11): 1922-1923.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Editorial, Introductory Journal Article
Impact factor: 3.9, 5-year impact factor Impact factor a 5 anni: 3.7
Url: Not available. Non disponibile.
Keywords Parole chiave: Bacteria Chemistry, Bacterial Infections Diagnosis Physiopathology, Biomarkers Analysis, Tumor Analysis Physiology, Drug Development, Humans, Neoplasms Diagnosis Physiopathology
Affiliations Affiliazioni:
*** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples, Italy.,
References Riferimenti:
Not available. Non disponibili.
Molecular Biomarkers of Disease for Diagnosis and Drug Development
Not available. Non disponibile.
Not available. Non disponibile.
Molecular Biomarkers of Disease for Diagnosis and Drug Development
No results. Nessun risultato. |
Molecular Biomarkers of Disease for Diagnosis and Drug Development
Sivaccumar JP, Leonardi A, Iaccarino E, Corvino G, Sanguigno L, Chambery A, Russo R, Valletta M, Latino D, Capasso D, Doti N, Ruvo M, Sandomenico A
* Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry (3 visite)
Int J Mol Sci (ISSN: 1422-0067linking), 2021 Mar 20; 22(6): N/D-N/D.
Impact Factor: 4.556
Dettagli Esporta in BibTeX Esporta in EndNote
Pedersen M, Irrera P, Dastrù W, Zöllner FG, Bennett KM, Beeman SC, Bretthorst GL, Garbow JR, Longo DL
* Dynamic Contrast Enhancement (DCE) MRI-Derived Renal Perfusion and Filtration: Basic Concepts (9 visite)
Methods Mol Biol (ISSN: 1064-3745linking), 2021; 2216: 205-227.
Impact Factor: 1.17
Dettagli Esporta in BibTeX Esporta in EndNote
Pohlmann A, Back SJ, Fekete A, Friedli I, Hectors S, Jerome NP, Ku MC, Longo DL, Meier M, Millward JM, Periquito JS, Seeliger E, Serai SD, Waiczies S, Sourbron S, Laustsen C, Niendorf T
* Recommendations for Preclinical Renal MRI: A Comprehensive Open-Access Protocol Collection to Improve Training, Reproducibility, and Comparability of Studies (8 visite)
Methods Mol Biol (ISSN: 1064-3745linking), 2021; 2216: 3-23.
Impact Factor: 1.17
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Irrera P, Consolino L, Sun PZ, Mcmahon MT
* Renal pH Imaging Using Chemical Exchange Saturation Transfer (CEST) MRI: Basic Concept (8 visite)
Methods Mol Biol (ISSN: 1064-3745linking), 2021; 2216: 241-256.
Impact Factor: 1.17
Dettagli Esporta in BibTeX Esporta in EndNote
Berisio R
* Molecular Biomarkers of Disease for Diagnosis and Drug Development (97 visite)
Curr Med Chem (ISSN: 0929-8673linking), 2019; 26(24): 4498-4500.
Impact Factor: 3.9
Dettagli Esporta in BibTeX Esporta in EndNote
De Maio F, Squeglia F, Goletti D, Delogu G
* The Mycobacterial HBHA Protein: a Promising Biomarker for Tuberculosis (184 visite)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2018 Oct 29; 26(11): 2051-2060.
Impact Factor: 3.519
Dettagli Esporta in BibTeX Esporta in EndNote
Squeglia F, Romano M, Ruggiero A, Berisio R
* Molecular players in Tuberculosis drug development: another break in the cell wall (268 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2017 Nov 24; 24(36): 3954-3969.
Impact Factor: 3.469
Dettagli Esporta in BibTeX Esporta in EndNote
Angapelly S, Ramya PVS, Angeli A, Monti SM, Buonanno M, Alvala M, Supuran CT, Arifuddin M
* Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors (227 visite)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391), 2017; 25(2): 539-544.
Impact Factor: 2.881
Dettagli Esporta in BibTeX Esporta in EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (385 visite)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
Dettagli Esporta in BibTeX Esporta in EndNote
Morelli G, Saviano M, Grieco P
* The renaissance era of peptides in drug discovery at the 14th Naples workshop on bioactive peptides (394 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617linking), 2015; 21(5): 321-322.
Impact Factor: 1.951
Dettagli Esporta in BibTeX Esporta in EndNote
Di Stasi R, Diana D, Capasso D, Palumbo R, Romanelli A, Pedone C, Fattorusso R, D'Andrea LD
* VEGFR1(D2) in drug discovery: Expression and molecular characterization (312 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2010; 94(6): 800-809.
Impact Factor: 2.572
Dettagli Esporta in BibTeX Esporta in EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (393 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
Dettagli Esporta in BibTeX Esporta in EndNote
12 Records (12 escludendo Abstract e Conferenze).
Impact factor totale: 35.083 (35.083 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 43.842 (43.842 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Sivaccumar JP, Leonardi A, Iaccarino E, Corvino G, Sanguigno L, Chambery A, Russo R, Valletta M, Latino D, Capasso D, Doti N, Ruvo M, Sandomenico A
* Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry (3 visite)
Int J Mol Sci (ISSN: 1422-0067linking), 2021 Mar 20; 22(6): N/D-N/D.
Impact Factor: 4.556
Dettagli Esporta in BibTeX Esporta in EndNote
Pedersen M, Irrera P, Dastrù W, Zöllner FG, Bennett KM, Beeman SC, Bretthorst GL, Garbow JR, Longo DL
* Dynamic Contrast Enhancement (DCE) MRI-Derived Renal Perfusion and Filtration: Basic Concepts (9 visite)
Methods Mol Biol (ISSN: 1064-3745linking), 2021; 2216: 205-227.
Impact Factor: 1.17
Dettagli Esporta in BibTeX Esporta in EndNote
Pohlmann A, Back SJ, Fekete A, Friedli I, Hectors S, Jerome NP, Ku MC, Longo DL, Meier M, Millward JM, Periquito JS, Seeliger E, Serai SD, Waiczies S, Sourbron S, Laustsen C, Niendorf T
* Recommendations for Preclinical Renal MRI: A Comprehensive Open-Access Protocol Collection to Improve Training, Reproducibility, and Comparability of Studies (8 visite)
Methods Mol Biol (ISSN: 1064-3745linking), 2021; 2216: 3-23.
Impact Factor: 1.17
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Irrera P, Consolino L, Sun PZ, Mcmahon MT
* Renal pH Imaging Using Chemical Exchange Saturation Transfer (CEST) MRI: Basic Concept (8 visite)
Methods Mol Biol (ISSN: 1064-3745linking), 2021; 2216: 241-256.
Impact Factor: 1.17
Dettagli Esporta in BibTeX Esporta in EndNote
Berisio R
* Molecular Biomarkers of Disease for Diagnosis and Drug Development (97 visite)
Curr Med Chem (ISSN: 0929-8673linking), 2019; 26(24): 4498-4500.
Impact Factor: 3.9
Dettagli Esporta in BibTeX Esporta in EndNote
De Maio F, Squeglia F, Goletti D, Delogu G
* The Mycobacterial HBHA Protein: a Promising Biomarker for Tuberculosis (184 visite)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2018 Oct 29; 26(11): 2051-2060.
Impact Factor: 3.519
Dettagli Esporta in BibTeX Esporta in EndNote
Squeglia F, Romano M, Ruggiero A, Berisio R
* Molecular players in Tuberculosis drug development: another break in the cell wall (268 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2017 Nov 24; 24(36): 3954-3969.
Impact Factor: 3.469
Dettagli Esporta in BibTeX Esporta in EndNote
Angapelly S, Ramya PVS, Angeli A, Monti SM, Buonanno M, Alvala M, Supuran CT, Arifuddin M
* Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors (227 visite)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391), 2017; 25(2): 539-544.
Impact Factor: 2.881
Dettagli Esporta in BibTeX Esporta in EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (385 visite)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
Dettagli Esporta in BibTeX Esporta in EndNote
Morelli G, Saviano M, Grieco P
* The renaissance era of peptides in drug discovery at the 14th Naples workshop on bioactive peptides (394 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617linking), 2015; 21(5): 321-322.
Impact Factor: 1.951
Dettagli Esporta in BibTeX Esporta in EndNote
Di Stasi R, Diana D, Capasso D, Palumbo R, Romanelli A, Pedone C, Fattorusso R, D'Andrea LD
* VEGFR1(D2) in drug discovery: Expression and molecular characterization (312 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2010; 94(6): 800-809.
Impact Factor: 2.572
Dettagli Esporta in BibTeX Esporta in EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (393 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
Dettagli Esporta in BibTeX Esporta in EndNote
12 Records (12 escludendo Abstract e Conferenze).
Impact factor totale: 35.083 (35.083 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 43.842 (43.842 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:41
223 views visite. Last view on Ultima visita in data Sunday 03 October 2021, 15:55:49
ibb.cnr.it